f Have We Placed the Cart Before the Horse by Using Alpha-2A Agonists to Treat Rejection Sensitivity Dysphoria in ADHD?

References

1. ReimherrF.W. RoeslerM. MarchantB.K. Types of adult attention deficit/hyperactivity disorder: A replication analysis.J. Clin. Psychol.2002812e1e7
   [Google Scholar]
2. WolraichM.L. ChanE. FroehlichT. ADHD diagnosis and treatment guidelines: A historical perspective.Pediatrics20191444e20191682
   [Google Scholar]
3. Diagnostic and Statistical Manual of Mental Disorders.3rd edWashington, DC, USAAmerican Psychiatric Association1980
   [Google Scholar]
4. KooijJ.J.S. BijlengaD. SalernoL. Updated European consensus statement on diagnosis and treatment of adult ADHD.Eur. Psychiatry2019561434
   [Google Scholar]
5. SibleyM. ChildressA. Why we need US guidelines for adults with ADHD. 2022. Available from: https://ibcces.org/learning/why-we-need-u-s-guidelines-for-adults-with-adhd/
6. StähleH. A historical perspective: Development of clonidine.Baillieres Clin. Anaesthesiol.200014237246
   [Google Scholar]
7. CornishL.A. Guanfacine hydrochloride: A centrally acting antihypertensive agent.Clin. Pharm.198873187197 3281788
   [Google Scholar]
8. GroomM.J. CorteseS. Current pharmacological treatments for ADHD.Curr. Top. Behav. Neurosci.202257195010.1007/7854_2022_330 35507282
   [Google Scholar]
9. Drug approval package.. Intuniv (guanfacine) NDA #022037. 2010. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022037_intuniv_toc.cfm
10. FiksA.G. MayneS.L. SongL. Changing patterns of alpha agonist medication use in children and adolescents 2009-2011.J. Child Adolesc. Psychopharmacol.201525436236710.1089/cap.2014.0122 25919708
    [Google Scholar]
11. NeuchatE.E. BockludB.E. KingsleyK. The role of alpha-2 agonists for attention deficit hyperactivity disorder in children: A review.Neurol. Int.202315269770710.3390/neurolint15020043 37218982
    [Google Scholar]